sanofi
| 4 min read
Elizabeth Laws leads Sanofi’s inflammation and immunology development pipeline to test the first oral TNFR1 inhibitor for rheumatoid arthritis and psoriasis.
Page 1 of 1 - 1 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Learn how to distinguish true extracellular vesicles from similarly sized particles using affinity capture and immunofluorescence.
Explore how a needs-driven approach to electronic laboratory notebook selection can improve data integrity, reproducibility, and scientific continuity.
Learn the fundamental weighing principles and operational controls that support reliable sample preparation.
